Table 3.
Subcutaneous dosing volume table
| Group | Study day | Dose volume (mL/day) |
|---|---|---|
| Group 1 | 11–13 45–47 79–81 |
7.9–10.9 9.8–14.9 10.9–16.7 |
| Group 2 | 11–13 45–47 79–81 |
2.6–4.3 3.3–5.6 3.7–6.4 |
| Group 3 | 11–13 45–47 79–81 |
5.5–7.7 6.9–10.0 7.6–11.7 |
| Group 4 | 11–13 45–47 79–81 |
7.8–11.3 10.4–14.4 11.0–17.0 |